BLFS - Biolife Solutions Inc
IEX Last Trade
25.87
-0.050 -0.193%
Share volume: 394,425
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$25.92
-0.05
-0.19%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-10 | 2022-08-09 | 2022-11-09 | 2023-03-31 | 2023-05-11 | 2023-08-09 | 2023-11-09 | 2024-02-29 | |
| Assets | |||||||||
| Total Assets | 544.012 M | 470.379 M | 487.679 M | 450.229 M | 446.470 M | 433.177 M | 411.152 M | 412.714 M | |
| Current Assets | 118.701 M | 118.057 M | 135.874 M | 138.452 M | 132.789 M | 120.311 M | 116.824 M | 120.604 M | |
| Inventories | 30.200 M | 33.335 M | 33.747 M | 34.904 M | 41.329 M | 39.177 M | 43.354 M | 43.456 M | |
| Other Current Assets | 4.757 M | 6.890 M | 8.041 M | 6.879 M | 6.201 M | 7.985 M | 7.854 M | 6.765 M | |
| Short Term Investments | 4.757 M | 6.890 M | 8.041 M | 6.879 M | 6.201 M | 7.985 M | 7.854 M | 6.765 M | |
| Total Receivables | 24.271 M | 31.257 M | 32.436 M | 33.936 M | 30.343 M | 26.860 M | 24.556 M | 18.657 M | |
| Current Cash | 59.463 M | 46.547 M | 61.619 M | 62.702 M | 54.885 M | 46.258 M | 41.029 M | 51.695 M | |
| Total Non-current Assets | 425.311 M | 352.322 M | 351.805 M | 311.777 M | 313.681 M | 312.866 M | 294.328 M | 292.110 M | |
| Property Plant Equipment | 18.259 M | 19.117 M | 21.737 M | 23.638 M | 26.100 M | 27.372 M | 20.998 M | 21.077 M | |
| Other Assets | 10.492 M | 9.773 M | 9.923 M | 9.617 M | 9.531 M | 9.733 M | 7.649 M | 8.080 M | |
| Intangible Assets | 149.286 M | 76.524 M | 74.013 M | 32.088 M | 30.629 M | 29.177 M | 22.064 M | 21.149 M | |
| Goodwill | 224.741 M | 224.741 M | 224.741 M | 224.741 M | 224.741 M | 224.741 M | 224.741 M | 224.741 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 544.012 M | 470.379 M | 487.679 M | 450.229 M | 446.470 M | 433.177 M | 411.152 M | 412.714 M | |
| Total liabilities | 65.492 M | 58.066 M | 79.430 M | 86.041 M | 88.363 M | 81.049 M | 79.135 M | 75.051 M | |
| Total current liabilities | 35.040 M | 33.298 M | 36.948 M | 44.582 M | 47.319 M | 39.587 M | 42.622 M | 42.178 M | |
| Accounts Payable | 11.711 M | 11.537 M | 13.140 M | 15.367 M | 15.525 M | 10.686 M | 11.980 M | 6.940 M | |
| Other liabilities | 3.081 M | 2.013 M | 3.246 M | 2.328 M | 1.880 M | 1.909 M | 363.000 K | 0.000 | |
| Current long term debt | 708.000 K | 1.516 M | 2.223 M | 1.972 M | 1.411 M | 2.361 M | 5.432 M | 7.209 M | |
| Long term debt | 6.566 M | 6.401 M | 24.373 M | 23.919 M | 23.787 M | 24.902 M | 22.187 M | 19.480 M | |
| Other liabilities | 3.081 M | 2.013 M | 3.246 M | 2.328 M | 1.880 M | 1.909 M | 363.000 K | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 478.520 M | 412.313 M | 408.249 M | 364.188 M | 358.107 M | 352.128 M | 332.017 M | 337.663 M | |
| Common stock | 42.014 M | 42.460 M | 42.648 M | 42.802 M | 43.028 M | 43.441 M | 43.570 M | 44.837 M | |
| Retained earnings | -112.086 M | -184.640 M | -194.597 M | -246.915 M | -260.629 M | -270.828 M | -299.960 M | -313.342 M |